Lista de obras -

A Personalized Physical Activity Program With Activity Trackers and a Mobile Phone App for Patients With Metastatic Breast Cancer: Protocol for a Single-Arm Feasibility Trial

article

A case of advanced non-Hodgkin's lymphoma involving the prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging

artículo científico publicado en 2010

Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1stline metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number

Abstract CT333: Elypse-7: A randomized, placebo-controlled, Phase 2a evaluating the impact of IL-7 immunotherapy on CD4 count, risks of severe haematological toxicity and tumor progression in metastatic breast cancer patients

article

Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme

artículo científico publicado en 2019

Advanced luminal breast cancer (hormone receptor-positive, HER2 negative): New therapeutic options in 2015

artículo científico publicado en 2015

Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer

artículo científico publicado en 2020

Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers

artículo científico publicado en 2019

Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial

artículo científico publicado en 2018

Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.

artículo científico publicado en 2016

Feasibility and Health Benefits of an Individualized Physical Activity Intervention in Women With Metastatic Breast Cancer: Intervention Study

artículo científico publicado en 2020

Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial

artículo científico publicado en 2019

GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian Cancer

artículo científico publicado en 2020

Head and neck sarcoma: report of a case treated by intensity-modulated radiation therapy

artículo científico publicado en 2010

Initial management of advanced ovarian cancer: What radiological, pathological and surgical information are important for optimal therapeutic strategy?

artículo científico publicado en 2015

Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer.

artículo científico publicado en 2017

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

artículo científico publicado en 2012

Mechanisms of resistance to endocrine therapies for breast cancer

artículo científico publicado en 2012

Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience

artículo científico publicado en 2009

Molecular biology of sarcoma and therapeutic choices

artículo científico publicado en 2015

Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibit

artículo científico publicado en 2013

New therapeutical strategies in metastatic hormone-dependent breast cancer

artículo científico publicado en 2015

Outcome of recurrent and metastatic small cell carcinoma of the bladder

artículo científico publicado en 2009

Pazopanib for the treatment of soft-tissue sarcoma ⬇️

artículo científico publicado el 26 de octubre de 2012

Physical activity preferences before and after participation in a 6-month physical activity intervention among women with metastatic breast cancer

artículo científico publicado en 2019

Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program

artículo científico publicado en 2019

Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study

artículo científico publicado en 2020

Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study

artículo científico publicado en 2016

Small cell cancer of the bladder: The Leon-Berard cancer centre experience

artículo científico publicado en 2008

Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)

artículo científico publicado en 2017

Systemic treatment of brain metastases from breast cancer: cytotoxic chemotherapy and targeted therapies

artículo científico publicado en 2013

Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region

artículo científico publicado en 2013

Therapeutic pipeline for soft-tissue sarcoma

artículo científico publicado en 2011

Therogenetics: transferring GWAS technology to the clinic

artículo científico publicado en 2015

Transmission of breast cancer polygenic risk based on single nucleotide polymorphisms

artículo científico publicado en 2018

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors

artículo científico publicado el 1 de septiembre de 2010

[The ConSoRe project supports the implementation of big data in oncology]

scientific article published on 02 November 2016

Lista de obras de

A Personalized Physical Activity Program With Activity Trackers and a Mobile Phone App for Patients With Metastatic Breast Cancer: Protocol for a Single-Arm Feasibility Trial

A case of advanced non-Hodgkin's lymphoma involving the prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging

Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1stline metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number

Abstract CT333: Elypse-7: A randomized, placebo-controlled, Phase 2a evaluating the impact of IL-7 immunotherapy on CD4 count, risks of severe haematological toxicity and tumor progression in metastatic breast cancer patients

Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme

Advanced luminal breast cancer (hormone receptor-positive, HER2 negative): New therapeutic options in 2015

Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer

Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers

Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial

Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.

Feasibility and Health Benefits of an Individualized Physical Activity Intervention in Women With Metastatic Breast Cancer: Intervention Study

Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial

GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian Cancer

Head and neck sarcoma: report of a case treated by intensity-modulated radiation therapy

Initial management of advanced ovarian cancer: What radiological, pathological and surgical information are important for optimal therapeutic strategy?

Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer.

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

Mechanisms of resistance to endocrine therapies for breast cancer

Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience

Molecular biology of sarcoma and therapeutic choices

Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibit

New therapeutical strategies in metastatic hormone-dependent breast cancer

Outcome of recurrent and metastatic small cell carcinoma of the bladder

Pazopanib for the treatment of soft-tissue sarcoma ⬇️

Physical activity preferences before and after participation in a 6-month physical activity intervention among women with metastatic breast cancer

Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program

Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study

Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study

Small cell cancer of the bladder: The Leon-Berard cancer centre experience

Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)

Systemic treatment of brain metastases from breast cancer: cytotoxic chemotherapy and targeted therapies

Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region

Therapeutic pipeline for soft-tissue sarcoma

Therogenetics: transferring GWAS technology to the clinic

Transmission of breast cancer polygenic risk based on single nucleotide polymorphisms

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors

[The ConSoRe project supports the implementation of big data in oncology]